Skip to main content
Log in

A clinical trial of Glenn type 3 attenuated poliovirus vaccine

  • Published:
Archiv für die gesamte Virusforschung Aims and scope Submit manuscript

Summary

A small clinical trial with the Glenn type 3 poliovirus vaccine has shown that the strain is antigenic and retains its attenuated characters on human passage at least as well as any other reported type 3 strain. The antigenicity and stability of the various type 3 vaccine strains should be compared in a larger clinical trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barnes, J. M., C. S. Heymann, andA. J. Beale: Ninth Symposium of the European Association against Poliomyelitis and Allied Diseases, Stockholm. Published by Masson et Cie, Paris (1963); p. 283.

    Google Scholar 

  • Benyesh-Melnick, M., andJ. L. Melnick: First International Conference on Live Poliovirus Vaccines. Scientific Publication No. 44; p. 179. Published by Pan American Sanitary Bureau. Regional Office of the W.H.O. Washington (1959).

    Google Scholar 

  • Clarke, S. K. A., A. P. Goffe, C. H. Stuart Harris, andE. G. Herzog: Brit. med. J.ii, 1188 (1958).

    Google Scholar 

  • Galbraith, N. S.: Ninth Symposium of the European Association against Poliomyelitis and Allied Diseases. Stockholm. Published by Masson et Cie, Paris; (1963); p. 92.

    Google Scholar 

  • Henderson, D. A., J. J. Witte, L. Morris, andA. D. Langmuir: J. Amer. med. Ass.190, 40 (1964).

    Google Scholar 

  • Hoskins, J. M.: Ninth Symposium of the European Association against Poliomyelitis and Allied Diseases, Stockholm. Published by Masson et Cie, Paris; (1963); p. 290.

    Google Scholar 

  • Miller, D. L., andN. S. Galbraith: Brit. med. J.ii, 504 (1965).

    Google Scholar 

  • Plotkin, S. A., T. W. Norton, Barbara J. Cohen, andH. Koprowski: Proc. Soc. exp. Biol. (N.Y.)107, 829 (1961).

    Google Scholar 

  • Sabin, A. B.: J. Amer. med. Ass.162, 1589 (1956).

    Google Scholar 

  • Sabin, A. B.: Brit. med. J.i, 663 (1959).

    Google Scholar 

  • Sabin, A. B.: Second International Conference on Live Poliovirus Vaccines. Scientific Publication 50 p. 101. Published by Pan American Sani tary Bureau. Regional Office of the W.H.O. Washington (1960).

    Google Scholar 

  • Stones, P.: International Symposium on Neurovirulence, Munich 1965; Symp. Series immunobiol Standard.2, 211 (1966).

    Google Scholar 

  • Terry, L. L.: A Technical Report. U.S. Dept. Hlth. Educ. Welfare (1962).

  • Vogt, M., R. Dulbecco, andH. A. Wenner: Virology4, 141 (1957).

    PubMed  Google Scholar 

  • W.H.O.: Expert Committee on Poliomyelitis Third Report. Wld Hlth Org. techn. Rep. Ser. No. 203 (1960).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barnes, J.M., Heymann, C.S., Galbraith, N.S. et al. A clinical trial of Glenn type 3 attenuated poliovirus vaccine. Archiv f Virusforschung 20, 296–304 (1967). https://doi.org/10.1007/BF01241949

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01241949

Keywords

Navigation